Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

830
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
830
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

868
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
868
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

452
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
452
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

247
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

307
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
307

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same author

Letter on 'Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors'. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms.

Neuroendocrinology·2026
Same author

Robust HLA-B-restricted CD8+ T-cell responses in chronic HBV infection.

JHEP reports : innovation in hepatology·2026
Same author

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Acute and chronic infections drive distinct trajectories in human memory CD4<sup>+</sup> T cell formation.

Immunity·2026

Related Experiment Video

Updated: Mar 12, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K

[Cholestatic liver disease].

Christine Pichler, Tobias Boettler, Robert Thimme

    Deutsche Medizinische Wochenschrift (1946)
    |November 18, 2016
    PubMed
    Summary

    Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are autoimmune liver diseases. While PBC has a diagnosis and treatment, PSC lacks established therapies, often requiring liver transplantation for advanced cases.

    Area of Science:

    • Hepatology
    • Autoimmune Diseases
    • Gastroenterology

    Background:

    • Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are common autoimmune cholestatic liver diseases.
    • The exact causes of these conditions remain unclear, though they often present with fatigue and pruritus.
    • Diagnosis and treatment vary significantly between PBC and PSC.

    Purpose of the Study:

    • To summarize the current understanding of primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).
    • To highlight diagnostic criteria and treatment options for both conditions.
    • To underscore the challenges in managing PSC compared to PBC.

    Main Methods:

    • Review of diagnostic markers for PBC, including alkaline phosphatase and antimitochondrial antibodies.

    More Related Videos

    Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
    08:56

    Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

    Published on: February 10, 2015

    55.1K
    Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
    12:36

    Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

    Published on: March 14, 2020

    17.9K

    Related Experiment Videos

    Last Updated: Mar 12, 2026

    The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
    07:27

    The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

    Published on: October 21, 2017

    12.5K
    Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
    08:56

    Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

    Published on: February 10, 2015

    55.1K
    Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
    12:36

    Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

    Published on: March 14, 2020

    17.9K
  • Description of diagnostic methods for PSC, focusing on alkaline phosphatase levels and cholangiography.
  • Examination of current treatment strategies for both conditions, including medical and surgical interventions.

    • Main Results:

    • PBC diagnosis is supported by elevated alkaline phosphatase and antimitochondrial antibodies; Ursodeoxycholic acid is the recommended treatment.
    • PSC diagnosis relies on elevated alkaline phosphatase and cholangiographic findings, with a high comorbidity of inflammatory bowel disease (up to 80%).
    • No definitive pharmacological therapy exists for PSC, though Ursodeoxycholic acid is used, and endoscopic management and liver transplantation are key interventions.

    Conclusions:

    • PBC is a well-defined autoimmune liver disease with established treatment protocols.
    • PSC presents greater management challenges due to the lack of specific therapies and its frequent association with inflammatory bowel disease.
    • Liver transplantation remains the definitive treatment for advanced stages of both PBC and PSC.